Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

874 ARTÍCULOS , VIENDO DEL 766 AL 780

Basal ganglia contributions to social cognition: evidence from movement disorders

Eddy CM.

Cogn Neuropsychiatry. 2025 Jan;30(1):1-14. doi: 10.1080/13546805.2025.2490054. Epub 2025 Apr 11.

Exploring Novel Therapeutic Avenues: Drug Repurposing for Neurodegenerative Movement Disorders

Bassi P, Rana S, Sapra V, Raina A, Kumar P, Devi S.

Curr Drug Res Rev. 2025;17(3):375-393. doi: 10.2174/0125899775327220240822111611.

Huntington's disease-like 2 patients' profile in a Brazilian cohort

Boone DL, Tumas V, Vilela G, Borges V, Rodrigues Pinto RAS, Costa MC, Ferraz HB.

Parkinsonism Relat Disord. 2025 Oct;139:108023. doi: 10.1016/j.parkreldis.2025.108023. Epub 2025 Sep 3.

Update on the Symptomatic Treatment of Huntington's Disease: From Pathophysiology to Clinical Practice

Olmedo-Saura G, Bernardi E, Bojtos L, Martínez-Horta S, Pagonabarraga J, Kulisevsky J, Pérez-Pérez J.

Int J Mol Sci. 2025 Jun 27;26(13):6220. doi: 10.3390/ijms26136220.

Challenges in studying disparities in neuropsychiatric hyperkinetic movement disorders

Dy-Hollins ME, Mendizabal A, Tsai AC.

Curr Opin Neurol. 2025 Aug 1;38(4):343-348. doi: 10.1097/WCO.0000000000001379. Epub 2025 May 16.

The microbiota-gut-brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets

Ekwudo MN, Gubert C, Hannan AJ.

FEBS J. 2025 Mar;292(6):1282-1315. doi: 10.1111/febs.17102. Epub 2024 Mar 1.

Systematic Review with Meta-Analysis of Biofluid Markers for Huntington's Disease

Paulsen JS, Bovin NA, Clemsen JD, Weiss A, Key AM, Janz ML, Pinto A, Burks DK, Zetterberg H, Shannon KM.

Mov Disord. 2025 Dec;40(12):2578-2595. doi: 10.1002/mds.70067. Epub 2025 Oct 13.

Genetic therapies for movement disorders - current status

Sartorelli J, Ng J, Rahim AA, Waddington SN, Kurian MA.

J Neurol. 2025 Feb 22;272(3):220. doi: 10.1007/s00415-025-12940-5.

Computer Vision Technologies in Movement Disorders: A Systematic Review

Pecoraro PM, Marsili L, Espay AJ, Bologna M, di Biase L.

Mov Disord Clin Pract. 2025 Sep;12(9):1229-1243. doi: 10.1002/mdc3.70123. Epub 2025 May 6.

Exploring the Role of Deutetrabenazine in the Treatment of Chorea Linked with Huntington's Disease

Tripathi S, Sharma Y, Kumar D.

Curr Rev Clin Exp Pharmacol. 2025;20(4):269-288. doi: 10.2174/0127724328312991241001051813.

Evaluation, Diagnosis, and Treatment of Sydenham Chorea: Consensus Guidelines

Thomas T, Eyre M, Ferrarin E, Newlove-Delgado T, Sie A, Armangue T, Ben-Pazi H, Benrhouma H, Clavenna A, Cardoso F, Dure LS, Jones HF, Gilbert DL, Gulati S, Jiang Y, Krajnc N, Mohammad SS, Orsini A, Sharma S, Swedo SE, Webb R, Wilmshurst JM, Yaramis A, Yilmaz S, Zuberi S, Morton M, Dale RC, Nosadini M, Lim M.

Pediatrics. 2025 Dec 1;156(6):e2025072466. doi: 10.1542/peds.2025-072466.

Pediatric Genetic Dystonias: Current Diagnostic Approaches and Treatment Options

Ceraolo G, Spoto G, Consoli C, Modafferi E, Di Rosa G, Nicotera AG.

Life (Basel). 2025 Jun 20;15(7):992. doi: 10.3390/life15070992.

The Digital Frontier in Huntington's Disease: Opportunities for Clinical Trials

Quinn L, Roché MW, Dorn J, Adams JL.

Mov Disord. 2025 Oct;40(10):2067-2076. doi: 10.1002/mds.30277. Epub 2025 Jul 14.

Neuroimaging Techniques in Huntington's Disease: A Critical Review

Farag M, Knights H, Scahill RI, McColgan P, Estevez-Fraga C.

Mov Disord Clin Pract. 2025 May;12(5):561-576. doi: 10.1002/mdc3.70010. Epub 2025 Feb 20.

Chorea associated with systemic lupus erythematosus- a systematic review

Julio PR, Capello CH, de Amorim JC, Andrade SO, Silveira-Moriyama L, Coan AC, Appenzeller S.

Lupus. 2025 Jun;34(7):687-698. doi: 10.1177/09612033251344045. Epub 2025 May 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias